title: Epidemiology of jellyfish stings reported to summer health centres in the Salento peninsula (Italy).
abstract: BACKGROUND
  The presence of jellyfish along coasts constitutes a potentially serious public health problem because of the toxic effects of contact with them.
  
  
  OBJECTIVE
  To determine the epidemiology of jellyfish stings in the Province of Lecce, Italy, in 2007.
  
  
  METHODS
  The study involved the gathering and processing of data on patients seeking medical treatment at summer first aid centres and hospitals along the coast of Salento following contact with jellyfish.
  
  
  RESULTS
  In 2007, 446 bathers sought medical assistance following contact with jellyfish. The spatial distribution indicates a greater frequency of stings sustained along the Adriatic coast, while the time analysis shows patterns related to wind direction. Most of the injuries were seen in persons aged between 1 and 10 years and in females. In 24% of cases, injuries were sustained to several parts of the body, while single injuries were mainly to the lower limbs (33%). In 4.9% of cases, there were complications, including one case of anaphylactic shock.
  
  
  CONCLUSIONS
  In the light of the significant level of medical assistance provided, there is a need to identify suitable strategies that will guarantee the best response in terms of both prevention and treatment.
authors.affiliation: Laboratory of Hygiene, Department of Biological and Environmental Science and Technology (DiSTeBA), University of Salento, 73100 Lecce, Italy. antonella.dedonno@unile.it
authors.forename: Antonella
authors.initials: A
authors.lastname: De Donno
authors.forename: Adele
authors.initials: A
authors.lastname: Idolo
authors.forename: Francesco
authors.initials: F
authors.lastname: Bagordo
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000554:Ambulatory Care Facilities; D000641:Ammonia / Q000008:administration & dosage; D000707:Anaphylaxis / Q000209:etiology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001733:Bites and Stings / Q000453:epidemiology* / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003063:Cnidaria; D003064:Cnidarian Venoms / Q000009:adverse effects; D003231:Conjunctivitis / Q000209:etiology; D004487:Edema / Q000209:etiology; D005260:Female; D005392:First Aid; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007558:Italy / Q000453:epidemiology; D035002:Lower Extremity; D008297:Male; D008875:Middle Aged; D012621:Seasons; D017678:Sex Distribution; D013035:Spasm / Q000209:etiology; D014581:Urticaria / Q000209:etiology
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D003064:Cnidarian Venoms; D006633:Histamine Antagonists; D000641:Ammonia